Health Catalyst, Inc.
HCAT
$4.18
$0.0651.58%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.80% | 33.16% | 58.56% | 37.97% | 15.29% |
| Total Depreciation and Amortization | -5.34% | -7.50% | -3.22% | -7.61% | -14.22% |
| Total Amortization of Deferred Charges | 48.37% | 54.12% | 8.20% | 7.84% | 0.12% |
| Total Other Non-Cash Items | -26.74% | -41.54% | -41.09% | 0.51% | -15.60% |
| Change in Net Operating Assets | 71.42% | 7.57% | 12.58% | 178.72% | -104.97% |
| Cash from Operations | 81.48% | 99.29% | 113.93% | 283.98% | -28.47% |
| Capital Expenditure | -61.96% | -373.15% | 28.75% | 51.06% | 38.55% |
| Sale of Property, Plant, and Equipment | -70.00% | -70.00% | -20.00% | -50.00% | 11.11% |
| Cash Acquisitions | -122.86% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -309.25% | 280.34% | 344.72% | 264.96% | 523.75% |
| Cash from Investing | -476.87% | 130.76% | 75.95% | 270.81% | 378.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -11.39% | -35.67% | -41.93% | -54.60% | -37.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9,441.77% | 10,716.83% | -41.93% | 827.96% | -37.99% |
| Foreign Exchange rate Adjustments | -382.35% | 653.33% | 33.33% | -480.00% | 112.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -795.99% | 710.25% | 102.95% | 453.93% | 242.88% |
